Oracle Corp. filings document the formal disclosure record for its enterprise software, database, cloud infrastructure, and cloud application business. Current reports cover quarterly operating and financial results, cloud revenue categories, dividends on common stock and mandatory convertible preferred stock, and the company’s NYSE-listed common stock and depositary shares.
Oracle’s SEC record also includes proxy and 8-K disclosures on board composition, executive appointments, compensation arrangements, annual meeting voting matters, material agreements, capital-structure matters, and other material events tied to corporate governance and financial reporting.
Oracle (ORCL): A holder filed a Form 144 notice to sell 5,000 shares of Oracle common stock, with an aggregate market value of $1,400,000. The planned sale is indicated for 10/21/2025 through Fidelity Brokerage Services LLC on the NYSE.
The shares were acquired via restricted stock vesting from the issuer in two tranches: 3,384 shares on 09/15/2024 and 1,616 shares on 08/03/2025. A Form 144 is a notice of a proposed sale under SEC Rule 144 and does not register new securities.
Oracle (ORCL) reported an insider transaction on a Form 4. On 10/10/2025, an officer (EVP, Chief Legal Officer) sold 19,758 shares of common stock at $300 per share, coded “S.” Following the sale, the officer beneficially owned 18,429 shares, held directly. The filing notes the sale was made under a Rule 10b5-1 trading plan adopted on July 10, 2025.
This Form 144 shows a proposed sale of 19,758 common shares of Oracle Corporation (ORCL) through Fidelity Brokerage Services LLC on the 10/10/2025. The filing lists an $5,927,400.00 aggregate market value and reports 2,841,714,000 shares outstanding. The securities were acquired by restricted stock vesting as compensation on 09/15/2024 (13,615 shares), 09/15/2025 (3,483), and 09/19/2025 (2,660). No sales in the past three months are reported. The signer certifies they are not aware of undisclosed material adverse information and, if applicable, notes any Rule 10b5-1 trading plan adoption date.
Oracle Corporation filed an amended report to update compensation details for recently promoted senior executives. The amendment follows earlier disclosures about the appointments of Clayton Magouyrk and Michael Sicilia as Chief Executive Officers and Board members, and Douglas Kehring as Executive Vice President and Principal Financial Officer, effective September 22, 2025.
On September 30, 2025, the Compensation Committee set the annual base salary for each of Magouyrk, Sicilia and Kehring at $950,000, effective as of the appointment date. For the fiscal year ending May 31, 2026, Magouyrk and Sicilia each received an annual target cash bonus opportunity of $5,000,000 under the Oracle Executive Bonus Plan, while Kehring received a target cash bonus of $950,000 under Oracle’s discretionary corporate bonus plan. Kehring is also eligible for ordinary course equity-based awards during FY26 under Oracle’s 2020 Equity Incentive Plan.
Douglas A. Kehring, Executive Vice President and Principal Financial Officer of Oracle Corp (ORCL), filed an initial Form 3 reporting his beneficial ownership. He directly owns 68,592 shares of Oracle common stock and indirectly holds 2,157.514 units through the company 401(k) plan. He also holds unvested restricted stock units totaling 212,... (213,101) RSUs from three prior grants that convert one-for-one to common shares upon settlement and vest in annual installments.
Mark Hura filed an initial Form 3 reporting his beneficial ownership in Oracle Corporation (ORCL) following his appointment as President, Global Field Operations. The filing reports 254,077 shares of Oracle common stock held directly and 162,959 unvested restricted stock units (RSUs) that each convert to one share at settlement. The RSUs come from three prior grants: 190,868 RSUs granted 09/20/2022 (vesting in four equal annual installments), 114,126 RSUs granted 09/15/2023 (four annual installments), and 77,571 RSUs granted 09/19/2024 (four annual installments).
The statement was signed by an attorney-in-fact on behalf of Mr. Hura on 10/01/2025 and reflects holdings as of the 09/22/2025 event date. All reported RSUs are unvested and scheduled to vest in equal annual tranches starting on each grant's first anniversary, indicating future potential share settlement rather than current voting shares.
Naomi O. Seligman, a director of Oracle Corporation (ORCL), reported transactions in Oracle common stock on 09/26/2025. The filing shows a sale of 2,222 shares at $288.91 (transaction code S), followed the same day by a gift of 1,406 shares (transaction code G) with no cash consideration. After those transactions the reporting person is shown as directly owning 29,225 shares following the sale and 27,819 shares following the gift. The filing discloses 6,000 shares held indirectly by spouse and 14,414 shares held indirectly by a trust. An administrative correction notes 10 shares were previously overreported. The Form 4 is signed by attorney-in-fact Aimee Weast on behalf of Ms. Seligman.
Michael D. Sicilia, listed as Chief Executive Officer, reported the acquisition of a large stock option award in Oracle Corporation (ORCL). The Form 4 shows a derivative transaction dated 09/24/2025 in which 1,037,412 stock options were acquired with an exercise (conversion) price of $308.46. The filing reports the options as directly beneficially owned following the transaction.
The options have an exercisable/expiration date entry of 09/24/2035 and the form states that 25% of the shares subject to the option vest annually on each anniversary of the grant date. The form is signed by an attorney-in-fact, Aimee Weast, under power of attorney dated 06/12/2025, with signature dated 09/26/2025.
Clayton M. Magouyrk, listed as Chief Executive Officer, reported a Section 16 Form 4 for Oracle Corporation (ORCL) reflecting a grant of stock options. The filing shows a derivative security described as a Stock Option with an exercise price of $308.46, dated 09/24/2025, for 2,593,530 option shares. The filing notes 25% of the shares subject to the option vest annually on each anniversary of the grant date. The reported options are held directly. The Form 4 was signed under power of attorney on 09/26/2025.
Oracle's definitive proxy discloses governance, succession and executive compensation actions for fiscal 2025. The company completed a planned CEO succession in September 2025: Safra Catz retired as CEO and PFO and became Executive Vice Chair, and Mr. Magouyrk and Mr. Sicilia were appointed as co-CEOs. Douglas Kehring was appointed Executive Vice President, Principal Financial Officer. The proxy calls for election of 13 directors, an advisory vote on named executive officer compensation, and ratification of Ernst & Young LLP as auditor for fiscal 2026.
The Compensation Committee elected not to pay annual cash bonuses for fiscal 2025 to preserve cash for strategic AI and growth priorities, and reduced performance-based bonuses to $0 (with one forfeiture noted). Long-term incentive outcomes included partial vesting of eight-year performance-based stock options. Key reported metrics include GAAP operating margin of 31% and GAAP earnings per share of $4.34. The proxy was first made available to stockholders on or about September 26, 2025.